Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 17-AAG | 0.0001 | uM | 9 | 156.25 | 71.09 | 151.00 | 118.00 | 1.2797 | 1.8024 |
| BT-20 | Erlotinib | 0.031623 | uM | 9 | 156.25 | 71.09 | 141.00 | 118.00 | 1.1949 | 1.5516 |
| BT-20 | Lapatinib | 1 | uM | 9 | 156.25 | 71.09 | 153.00 | 118.00 | 1.2966 | 1.8533 |
| BT-20 | Linsitinib | 10 | uM | 9 | 156.25 | 71.09 | 127.00 | 118.00 | 1.0763 | 1.2115 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 156.25 | 71.09 | 187.00 | 118.00 | 1.5847 | 2.7545 |
| BT-20 | Erlotinib | 10 | uM | 9 | 156.25 | 71.09 | 123.00 | 118.00 | 1.0424 | 1.1168 |
| BT-20 | Linsitinib | 0.31623 | uM | 9 | 156.25 | 71.09 | 143.00 | 118.00 | 1.2119 | 1.6013 |
| BT-20 | Linsitinib | 0.0033113 | uM | 9 | 156.25 | 71.09 | 115.00 | 118.00 | 0.9746 | 0.9308 |
| BT-20 | 17-AAG | 0.01 | uM | 9 | 156.25 | 71.09 | 63.00 | 118.00 | 0.5339 | -0.1523 |
| BT-20 | Lapatinib | 3.1623 | uM | 9 | 156.25 | 71.09 | 119.00 | 118.00 | 1.0085 | 1.0232 |
| BT-20 | 17-AAG | 0.001 | uM | 9 | 156.25 | 71.09 | 155.00 | 118.00 | 1.3136 | 1.9044 |
| BT-20 | 0 | uM | 9 | 156.25 | 71.09 | 114.00 | 118.00 | 0.9661 | 0.9078 | |
| BT-20 | 17-AAG | 0.0031623 | uM | 9 | 156.25 | 71.09 | 108.00 | 118.00 | 0.9153 | 0.7718 |
| BT-20 | Linsitinib | 1 | uM | 9 | 156.25 | 71.09 | 112.00 | 118.00 | 0.9492 | 0.8622 |
| BT-20 | 0 | uM | 9 | 156.25 | 71.09 | 76.00 | 118.00 | 0.6441 | 0.0956 | |
| BT-20 | 0 | uM | 9 | 156.25 | 71.09 | 89.00 | 118.00 | 0.7542 | 0.3598 | |
| BT-20 | Linsitinib | 19.9526 | uM | 9 | 156.25 | 71.09 | 84.00 | 118.00 | 0.7119 | 0.2564 |
| BT-20 | Linsitinib | 3.1623 | uM | 9 | 156.25 | 71.09 | 158.00 | 118.00 | 1.3390 | 1.9816 |
| BT-20 | Lapatinib | 0.0033113 | uM | 9 | 156.25 | 71.09 | 125.00 | 118.00 | 1.0593 | 1.1640 |
| BT-20 | Erlotinib | 0.0033113 | uM | 9 | 156.25 | 71.09 | 96.00 | 118.00 | 0.8136 | 0.5082 |
| BT-20 | Linsitinib | 0.1 | uM | 9 | 156.25 | 71.09 | 124.00 | 118.00 | 1.0508 | 1.1404 |
| BT-20 | Lapatinib | 0.1 | uM | 9 | 156.25 | 71.09 | 123.00 | 118.00 | 1.0424 | 1.1168 |
| BT-20 | 0 | uM | 9 | 156.25 | 71.09 | 149.00 | 118.00 | 1.2627 | 1.7517 | |
| BT-20 | 17-AAG | 0.000066069 | uM | 9 | 156.25 | 71.09 | 169.00 | 118.00 | 1.4322 | 2.2691 |
| BT-20 | 0 | uM | 9 | 156.25 | 71.09 | 151.00 | 118.00 | 1.2797 | 1.8024 |